Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Articolo scientifico
29 mag 2026 0
Risultati per "Bempedoic Acid"
20 articoli
Longevity & Aging
L'Acido Bempedoico È Risultato Sufficientemente Sicuro da Consentire la Continuazione dell'Allattamento al Seno
Le nuove linee guida suggeriscono che le madri che assumono acido bempedoico per il colesterolo non debbano necessariamente interrompere l'allattamento al seno, sebbene sia raccomandata cautela nel caso di neonati.
Articolo scientifico
7 giu 2026 0
Heart Health
La combinazione di acido bempedoico ed Ezetimibe riduce LDL nei pazienti diabetici
Uno studio di fase 2 verifica se una pillola a dosaggio fisso combinato possa abbassare in modo sicuro il LDL colesterolo nelle persone con diabete di tipo 2.
Sperimentazione clinica
17 giu 2026 0
Metabolic Health
Cholesterol Drug Bempedoic Acid Activates Key Fat-Burning Pathway in Liver Cells
New research reveals how the cholesterol medication bempedoic acid directly activates PPARα, boosting fat metabolism beyond its known effects.
Articolo scientifico
29 mar 2026 3
Longevity & Aging
BHB Supplement Shields Brain from Damage Caused by Saturated Fat Diets
Beta-hydroxybutyrate restores AMPA receptor function and prevents memory loss triggered by saturated fat-rich diets in mice.
Articolo scientifico
31 mag 2026 0
Brain Health
La Molecola di Acido Grasso Erucamide Arresta la Degenerazione Retinica nei Topi
Un acido grasso ammide naturalmente presente attiva le cellule immunitarie della retina, proteggendo i neuroni e i vasi sanguigni dai danni degenerativi.
Articolo scientifico
21 giu 2026 0
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Sperimentazione clinica
13 mag 2026 0
Longevity & Aging
FDA Approves First-in-Class Blood Pressure Pill That Targets Aldosterone at the Source
Baxdrostat blocks aldosterone production directly, cutting systolic BP by ~15 mmHg in resistant hypertension patients who failed other drugs.
Comunicato stampa
19 mag 2026 0
Metabolic Health
FDA Approves Baxfendy, a New Aldosterone Synthase Inhibitor for Hypertension
Baxdrostat becomes the first-in-class aldosterone synthase inhibitor approved to treat resistant hypertension alongside existing drugs.
Approvazione farmaco
19 mag 2026 0
Longevity & Aging
Il Composto Vegetale Epiberberina Controlla l'Infiammazione Intestinale Correggendo il Riciclo degli Acidi Biliari
Un alcaloide naturale della medicina tradizionale cinese attiva un recettore chiave degli acidi biliari per ripristinare l'equilibrio intestinale e ridurre l'infiammazione della colite.
Articolo scientifico
4 giu 2026 0
Longevity & Aging
BPC 157 Peptide Controls Angiogenesis and Nitric Oxide for Broad Healing Benefits
A comprehensive review argues that BPC 157's effects on angiogenesis and nitric oxide are therapeutic assets, not risks, with anti-tumor and neuroprotective evidence.
Articolo scientifico
31 mag 2026 0
Brain Health
Herbal Compound Clears Alzheimer's Plaques by Activating AMPK Autophagy Pathway
A traditional Chinese herbal formula improves cognition and cerebrovascular health in Alzheimer's mice by activating the LKB1-AMPK-SIRT1 autophagy cascade.
Articolo scientifico
21 mag 2026 0
Longevity & Aging
BPC 157 Defends Against Cancer and Neurodegeneration by Mastering Angiogenesis and Nitric Oxide
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
Articolo scientifico
18 mag 2026 0
Longevity & Aging
FDA Approves First Aldosterone Synthase Inhibitor BAXFENDY to Tackle Resistant Hypertension
AstraZeneca's BAXFENDY cuts systolic blood pressure by nearly 10 mmHg beyond placebo in adults whose BP wasn't controlled by other drugs.
Comunicato stampa
20 mag 2026 0
Longevity & Aging
Methylene Blue Cuts Postoperative Delirium by Calming Brain Inflammation
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
Articolo scientifico
18 mag 2026 0
Longevity & Aging
La Berberina Protegge il Fegato Potenziando l'Efficacia dell'Evodiamina contro la Colite
Combinare due composti erboristici tradizionali risolve un pericoloso problema di tossicità epatica rendendo al contempo il trattamento della colite significativamente più efficace.
Articolo scientifico
6 giu 2026 0
Longevity & Aging
NACET Compound Activates Cellular Defense Against Age-Related Eye Disease
Modified antioxidant shows promise for preventing diabetic retinopathy and macular degeneration by boosting cellular protection.
Articolo scientifico
19 apr 2026 0
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Sperimentazione clinica
28 mar 2026 1
Longevity & Aging
Methylene Blue Emerges as a Versatile Clinical Tool Beyond Emergency Medicine
A comprehensive review reveals methylene blue's expanding role from toxicology emergencies to perioperative care, neurology, and oncology.
Articolo scientifico
13 mag 2026 0
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Sperimentazione clinica
29 mar 2026 0
Pagina 1 di 2Avanti